Marmara University

Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

Retrieved on: 
Monday, April 8, 2024
Diagnosis, Istanbul University, Marmara University, Tekirdağ Namık Kemal University, Research, Mammography, Cancer, AI, Woman, MMG, Breast cancer, Workload, Therapy, ESR, Medical imaging

SEOUL, South Korea, April 8, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study, highlighting the effectiveness of Lunit INSIGHT MMG in significantly reducing radiologists' workload while enhancing cancer detection rates.

Key Points: 
  • This comprehensive study encompassed over 22,621 mammograms from 8,825 women over a decade.
  • Utilizing Lunit INSIGHT MMG, Lunit's AI-powered solution for breast cancer detection, the research aimed to assess its proficiency in early cancer detection within a breast cancer screening program.
  • This indicates a substantial step forward in improving the efficiency of breast cancer screening programs, potentially enabling broader screening coverage and reducing the burden on healthcare systems.
  • The study further revealed that the AI system identified 51.72% of interval cancers, and 50% of missed cancers.

BlueSphere Bio Appoints Erkut Bahceci, M.D., as Chief Medical Officer

Retrieved on: 
Monday, January 30, 2023
AML, Medicine, National Institutes of Health, Acute leukemia, Astellas Pharma, Lymphatic system, Mercy Hospital, Immunotherapy, Cancer, Marmara University, TCR, ALL, Takeda Pharmaceutical Company, Therapy, Pediatric Hematology and Oncology, CAR, Drug development, MDS, Patient, National Heart, Lung, and Blood Institute, Clinical trial, Dasatinib, Acute myeloid leukemia, Faculty, Oncology, Senior, Internal medicine, Associate, Research, Bayer, Pharmaceutical industry, Hematology, Takeda

PITTSBURGH, Pa., Jan. 30, 2023 (GLOBE NEWSWIRE) -- BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform and novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced the appointment of Erkut Bahceci, M.D., as Chief Medical Officer.

Key Points: 
  • PITTSBURGH, Pa., Jan. 30, 2023 (GLOBE NEWSWIRE) -- BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform and novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced the appointment of Erkut Bahceci, M.D., as Chief Medical Officer.
  • Dr. Bahceci added, “This is an incredibly exciting time to join BlueSphere Bio.
  • Despite the effectiveness of allogeneic stem cell transplants for a broad range of hematological malignancies, a significant number of patients relapse.
  • He began his career in the pharmaceutical industry at Bayer, where he served as Associate Director of Medical Sciences-Oncology.

Boyden Welcomes New Team in Turkey

Retrieved on: 
Tuesday, January 17, 2023
Real estate, Garanti BBVA, Consultant, Carrefour, Economics, Arthur Andersen, SMART Business Advisory and Consulting, Marmara University, United Arab Emirates, Human, Management, Unilever

ISTANBUL, Turkey, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Boyden, a premier leadership and talent advisory firm with more than 70 offices in over 45 countries, is delighted to announce the arrival of a new leadership team in Turkey, Murat Ergene and Ibrahim Paksoy.

Key Points: 
  • ISTANBUL, Turkey, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Boyden, a premier leadership and talent advisory firm with more than 70 offices in over 45 countries, is delighted to announce the arrival of a new leadership team in Turkey, Murat Ergene and Ibrahim Paksoy.
  • “We are delighted to join Boyden, a firm we have known very closely,” said Murat Ergene Managing Partner, Country Leader Boyden Turkey.
  • “Our local strength, combined with Boyden’s global synergy and capabilities will provide valuable services to clients in Turkey and worldwide.
  • İbrahim holds a Master’s degree in finance from Koç University, and a Bachelor’s degree in economics from Marmara University.

Sisecam Announces Intention to Appoint Senior Management at Sisecam Chemicals Resources LLC and its Subsidiaries

Retrieved on: 
Friday, February 11, 2022
Professional Services, Packaging, Chemicals, Plastics, Mining, Minerals, Manufacturing, Natural Resources, Finance, Institute of technology, Harvard Business School, CFO, Telecommunication, General partnership, Middle East Technical University, Intention, Ciner Wyoming, Marmara University, Effective date, Ciner Group, Glass, Acquisition, CIS, General partner, Dokuz Eylül University, Economics, Bachelor of Science, Management, Science

Sisecam Chemicals USA Inc. (Sisecam US), a wholly owned subsidiary of Turkiye Sise ve Cam Fabrikalari A.S. of Istanbul, Turkey (together with Sisecam US, Sisecam) today announced its intention to appoint Ertugrul Kaloglu as Chief Executive Officer and Mehmet Nedim Kulaksizoglu as Chief Financial Officer of Sisecam Chemicals Resources LLC (Sisecam Resources) and its subsidiaries, including Ciner Resource Partners LLC (the General Partner) upon the receipt of all requisite US immigration and corporate approvals (the Effective Date).

Key Points: 
  • Sisecam Chemicals USA Inc. (Sisecam US), a wholly owned subsidiary of Turkiye Sise ve Cam Fabrikalari A.S. of Istanbul, Turkey (together with Sisecam US, Sisecam) today announced its intention to appoint Ertugrul Kaloglu as Chief Executive Officer and Mehmet Nedim Kulaksizoglu as Chief Financial Officer of Sisecam Chemicals Resources LLC (Sisecam Resources) and its subsidiaries, including Ciner Resource Partners LLC (the General Partner) upon the receipt of all requisite US immigration and corporate approvals (the Effective Date).
  • Sisecam obtained these management appointment rights in connection with its acquisition of 60% of Sisecam Resources in December 2021.
  • He is currently the Chief Financial Officer of Pacific Soda LLC, a joint venture between Sisecam and the Ciner Group, which indirectly owns 40% of Sisecam Resources.
  • Sisecam is a global player in soda ash, chromium chemicals, flat glass, auto glass, glassware glass packaging and glass fiber sectors.

CICV, Marmara University and BigTRI Join the International Alliance for Mobility Testing & Standardization

Retrieved on: 
Tuesday, November 23, 2021
CAV, International Alliance of Theatrical Stage Employees, Andative and venitive, Marmara University, Environment, Simulation, Transport, Internet of things, Health, Student, IOT, Education, Solution, 2600-series (CTA), CAAM, Laboratory, SAE International, Ministry, Intelligence, City, National Innovation Center, Hope, Pleasure, Research, Automotive engineering, SAE, Ministry of Industry and Information Technology, Organization, CDMA mobile test set, Digital twin, V2X, Certification, Information technology, Renewable energy

Bringing in Maramara University and BigTRI further expands our membership into the innovative and expanding market of Turkey."

Key Points: 
  • Bringing in Maramara University and BigTRI further expands our membership into the innovative and expanding market of Turkey."
  • "Being a part of IAMTS means being at the heart of testing, standardization, and certification of advanced mobility systems and services.
  • IAMTS, is a global, membership-based alliance of organizations involved in the testing, standardization and certification of advanced mobility systems and services.
  • The alliance works to develop and grow an international portfolio of smart mobility testbeds that meet the highest quality implementation and operational standards.